Profil
Brian DeSchuytner worked at Millennium Pharmaceuticals, Inc. from 2009 to 2017 as VP-Global Marketing & Head-Global Brand.
From 2017 to 2019, worked at Tesaro, Inc. as Vice President-ZEJULA Commercial.
From 2019 to 2026, worked at Mersana Therapeutics, Inc., serving as Chief Operating & Financial Officer, Senior VP from 2023 to 2026.
Education includes an undergraduate degree from Dartmouth College and an MBA from The Wharton School of the University of Pennsylvania.
Anciens postes connus de Brian DeSchuytner
| Sociétés | Poste | Fin |
|---|---|---|
| MERSANA THERAPEUTICS | Directeur Financier/CFO | 06/01/2026 |
| TESARO INC | Corporate Officer/Principal | 01/06/2019 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | 01/01/2017 |
Formation de Brian DeSchuytner
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Mersana Therapeutics, Inc.
Mersana Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures antibody drug conjugates to improve patient outcomes in multiple oncology indications | Health Technology |
Tesaro, Inc.
Tesaro, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for cancer patients | Health Technology |
Dartmouth College
Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















